Ekso Bionics Holdings, Inc. (LON:0IFR)

Market Cap	9.54M
Revenue (ttm)	13.19M
Net Income (ttm)	-8.30M
Shares Out	n/a
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Average Volume	16,251
Open	0.558
Previous Close	0.593
Day's Range	0.558 - 0.558
52-Week Range	0.486 - 2.381
Beta	1.88
RSI	41.79
Earnings Date	Feb 24, 2025

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The com...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2005
• Employees: 72
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IFR

Financial Performance

In 2023, Ekso Bionics Holdings's revenue was $18.28 million, an increase of 41.57% compared to the previous year's $12.91 million. Losses were -$15.20 million, 0.78% more than in 2022.

Financial numbers in USD